News Assobiotec virtual fireside chat series: Venture Capital in the biotech sector Date: May 9, 2024 Time: 5:00 PM CET Speakers: Pierluigi Paracchi, CEO Genenta Science; Ileana Pirozzi, Healthcare Investments Lead Exor Ventures See details Visit Genenta Science Linkedin NOTICE OF CALL OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS’ MEETING 2024 AVVISO DI CONVOCAZIONE DI ASSEMBLEA ORDINARIA E STRAORDINARIA 2024 Date: March 29, 2024 Visit Genenta Science Linkedin Press Releases Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors Feb 08, 2024 Genenta to Present at Upcoming Scientific and Investor Conferences Sep 06, 2023 Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments Jul 28, 2023 Learn More Upcoming Events Chardan’s 8th Annual Genetic Medicines Conference, virtual event Apr 29 - Apr 30, 2024 Aegis, virtualconference May 7, 2024 Assobiotec virtual fireside chat series: Venture Capital in the biotech sector May 9, 2024 at 5:00 PM CEST Learn More Learn More Corporate Information Genenta Corporate Deck Apr 18, 2024 Request to call the shareholders’ meeting pursuant to Article 9.1 of the Bylaws and Article 2367 of the Italian Civil Code Mar 30, 2024 RELAZIONE ILLUSTRATIVA DEL CONSIGLIO DI AMMINISTRAZIONE ALL'ASSEMBLEA ORDINARIA DEGLI AZIONISTI 2024 Mar 30, 2024 Richiesta convocazione assembleare ai sensi dell’articolo 9.1 dello statuto e dell’articolo 2367 del codice civile Mar 30, 2024 ILLUSTRATIVE REPORT OF THE BOARD OF DIRECTORS TO THE ORDINARY SHAREHOLDERS' MEETING 2024 Mar 30, 2024 Notice of Call of the Ordinary and Extraordinary Shareholders’ Meeting 2024 Mar 29, 2024 Avviso di convocazione di assemblea ordinaria e straordinaria 2024 Mar 29, 2024 Financial Metrics Price Change Day High Day Low Volume Apr 26, 2024 1:01 PM EDT Stock Chart Data Provided by Refinitiv. Minimum 15 minutes delayed. Learn More
Assobiotec virtual fireside chat series: Venture Capital in the biotech sector Date: May 9, 2024 Time: 5:00 PM CET Speakers: Pierluigi Paracchi, CEO Genenta Science; Ileana Pirozzi, Healthcare Investments Lead Exor Ventures See details Visit Genenta Science Linkedin NOTICE OF CALL OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS’ MEETING 2024 AVVISO DI CONVOCAZIONE DI ASSEMBLEA ORDINARIA E STRAORDINARIA 2024 Date: March 29, 2024 Visit Genenta Science Linkedin
Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors Feb 08, 2024
Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments Jul 28, 2023
Assobiotec virtual fireside chat series: Venture Capital in the biotech sector May 9, 2024 at 5:00 PM CEST
Request to call the shareholders’ meeting pursuant to Article 9.1 of the Bylaws and Article 2367 of the Italian Civil Code Mar 30, 2024
RELAZIONE ILLUSTRATIVA DEL CONSIGLIO DI AMMINISTRAZIONE ALL'ASSEMBLEA ORDINARIA DEGLI AZIONISTI 2024 Mar 30, 2024
Richiesta convocazione assembleare ai sensi dell’articolo 9.1 dello statuto e dell’articolo 2367 del codice civile Mar 30, 2024
ILLUSTRATIVE REPORT OF THE BOARD OF DIRECTORS TO THE ORDINARY SHAREHOLDERS' MEETING 2024 Mar 30, 2024